Literature DB >> 3486453

The human cell surface glycoprotein complex (gp 120,200) recognized by monoclonal antibody K20 is a component binding to phytohaemagglutinin on T cells.

M Amiot, A Bernard, H C Tran, G Leca, J M Kanellopoulos, L Boumsell.   

Abstract

Monoclonal antibody K20 recognizes a human glycoprotein complex that is not restricted to haematopoietic lineages but is preferentially expressed on early haematopoietic cells, T cells, and monocytes. This glycoprotein complex is made of a constant 120,000-140,000 Mr subunit noncovalently associated at the cell surface with subunits of higher Mr ranging from 150,000 to 200,000 on different cell types. Internal labelling with [35S]methionine and pulse-chase experiments revealed that in the cell the 120,000 Mr glycoprotein of this complex is also noncovalently associated with a 100,000 Mr glycoprotein, and that both glycoproteins are independently biosynthesized. This glycoprotein complex is shown by immunoprecipitation by lectin plus antilectin antibodies and by sequential immunoprecipitations to be one of the cell surface structures bound by phytohaemagglutinin on the surface of normal T cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486453     DOI: 10.1111/j.1365-3083.1986.tb01948.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  21 in total

1.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  A monoclonal antibody against an activation epitope on mouse integrin chain beta 1 blocks adhesion of lymphocytes to the endothelial integrin alpha 6 beta 1.

Authors:  M Lenter; H Uhlig; A Hamann; P Jenö; B Imhof; D Vestweber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

Review 3.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

4.  Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms.

Authors:  G O Delwel; A A de Melker; F Hogervorst; L H Jaspars; D L Fles; I Kuikman; A Lindblom; M Paulsson; R Timpl; A Sonnenberg
Journal:  Mol Biol Cell       Date:  1994-02       Impact factor: 4.138

5.  Identification of the cleavage sites in the alpha6A integrin subunit: structural requirements for cleavage and functional analysis of the uncleaved alpha6Abeta1 integrin.

Authors:  G O Delwel; I Kuikman; R C van der Schors; A A de Melker; A Sonnenberg
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

6.  Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases.

Authors:  K Koretz; P Schlag; L Boumsell; P Möller
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

7.  Expression of beta 1 integrins in non-neoplastic mammary epithelium, fibroadenoma and carcinoma of the breast.

Authors:  G Mechtersheimer; M Munk; T Barth; K Koretz; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Focal adhesions are sites of integrin extension.

Authors:  Janet A Askari; Christopher J Tynan; Stephen E D Webb; Marisa L Martin-Fernandez; Christoph Ballestrem; Martin J Humphries
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

9.  Entrance and survival of Salmonella typhimurium and Yersinia enterocolitica within human B- and T-cell lines.

Authors:  G M Verjans; J H Ringrose; L van Alphen; T E Feltkamp; J G Kusters
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells.

Authors:  G Mechtersheimer; T Barth; A Quentmeier; P Möller
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.